Yayın:
Addiction to topically used cyclopentolate hydrochloride: A case report

Basit Görünüm
dc.contributor.buuauthorAkkaya, Cengiz
dc.contributor.buuauthorZorlu Kocagoz, Sevilay
dc.contributor.buuauthorSarandöl, Aslı
dc.contributor.buuauthorEker, Salih Saygın
dc.contributor.buuauthorKırlı, Selçuk
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentPsikiyatri Ana Bilim Dalı
dc.contributor.researcherid
dc.contributor.scopusid14061855100
dc.contributor.scopusid24492525800
dc.contributor.scopusid14020405100
dc.contributor.scopusid14019347700
dc.contributor.scopusid14019745700
dc.date.accessioned2024-03-20T11:59:17Z
dc.date.available2024-03-20T11:59:17Z
dc.date.issued2008-10-01
dc.description.abstract
dc.identifier.citationAkkaya, C. vd. (2008). "Addiction to topically used cyclopentolate hydrochloride: A case report". Progress in Neuro-Psychopharmacology and Biological Psychiatry, 32(7), 1752-1753
dc.identifier.doi10.1016/j.pnpbp.2008.07.003
dc.identifier.endpage1753
dc.identifier.issn0278-5846
dc.identifier.issn1878-4216
dc.identifier.issue7
dc.identifier.pubmed18674584
dc.identifier.scopus2-s2.0-51349152656
dc.identifier.startpage1752
dc.identifier.urihttps://doi.org/10.1016/j.pnpbp.2008.07.003
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S0278584608002017
dc.identifier.urihttps://hdl.handle.net/11452/40526
dc.identifier.volume32
dc.identifier.wos000259843500025
dc.indexed.scopusScopus
dc.indexed.wosSCIE
dc.language.isoen
dc.publisherElsevier
dc.relation.journalProgress in Neuro-Psychopharmacology and Biological Psychiatry
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectNeurosciences & neurology
dc.subjectPsychiatry
dc.subjectPharmacology & pharmacy
dc.subjectAbuse
dc.subject.emtreeCarbamazepine
dc.subject.emtreeCholinergic receptor blocking agent
dc.subject.emtreeCyclopentolate
dc.subject.emtreeDexamethasone
dc.subject.emtreeEscitalopram
dc.subject.emtreeFluoxetine
dc.subject.emtreeMethylprednisolone
dc.subject.emtreePimozide
dc.subject.emtreeRisperidone
dc.subject.emtreeSertraline
dc.subject.emtreeAddiction
dc.subject.emtreeAdult
dc.subject.emtreeAlcohol abuse
dc.subject.emtreeBehcet disease
dc.subject.emtreeCase report
dc.subject.emtreeDepression
dc.subject.emtreeDrug dose escalation
dc.subject.emtreeDrug substitution
dc.subject.emtreeFollow up
dc.subject.emtreeHuman
dc.subject.emtreeLetter
dc.subject.emtreeMajor depression
dc.subject.emtreeMale
dc.subject.emtreePatient compliance
dc.subject.emtreeUveitis
dc.subject.emtreeVisual impairment
dc.subject.meshAdult
dc.subject.meshCyclopentolate
dc.subject.meshHumans
dc.subject.meshMale
dc.subject.meshMuscarinic antagonists
dc.subject.meshSubstance-related disorders
dc.subject.otherClinical neurology
dc.subject.scopusCase Report; Tropicamide; Orphenadrine
dc.subject.wosClinical Neurology
dc.subject.wosNeurosciences
dc.subject.wosPharmacology & Pharmacy
dc.subject.wosPsychiatry
dc.titleAddiction to topically used cyclopentolate hydrochloride: A case report
dc.typeLetter
dc.wos.quartileQ2
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Psikiyatri Ana Bilim Dalı
local.indexed.atPubMed
local.indexed.atScopus

Dosyalar

Lisanslı seri

Şimdi gösteriliyor 1 - 1 / 1
Placeholder
Ad:
license.txt
Boyut:
1.71 KB
Format:
Item-specific license agreed upon to submission
Açıklama
İndir

Koleksiyonlar

İndeksli Yayınlar / Indexed Publications